medigraphic.com

2003, Número 1

<< Anterior Siguiente >>

Rev Mex Anest 2003; 26 (1)


Manejo Anestésico de la Cirugía Vascular Periférica

Reyes ER, Vásquez MMA, Guadarrama QF, Rubio MR, Cendón OM, Ortega GJ, Luna OP

Idioma: Español
Referencias bibliográficas: 98
Paginas: 28-37
Archivo PDF: 166.44 Kb.


RESUMEN

La enfermedad arterial periférica, definida como una patología de los vasos sanguíneos periféricos que limita el paso de la sangre a los tejidos (afectando principalmente extremidades inferiores), tiene una prevalencia del 10% en personas mayores de 60 años. Su tratamiento resulta en la mayoría de los casos quirúrgico. Al conocer los aspectos demográficos y las patologías co-existentes de los pacientes que ingresan al quirófano, nos daremos cuenta del panorama integral, ya que, en la mayoría de los casos, la patología arterial periférica, resulta un reflejo de una serie de afecciones sistémicas. Existen varias técnicas anestésicas que podemos ofrecer a éstos pacientes, es por eso que en este articulo se exponen las ventajas y desventajas de la anestesia general y la regional, así como estudios que apoyan una u otra .


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Luna P. Cirugía Vascular Periférica, en: Luna P., Anestesia en el cardiópata. México, Mc Graw Hill, 2002.

  2. Valentine RJ. Jackson MR. Modrall JG. McIntyre KE. Clagett GP. The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service. Journal of Vascular Surgery. 1999; 30(3):436-44.

  3. Criqui MH. Peripheral arterial disease - epidemiological aspects. Vascular Medicine. 2001; 6 (3 Suppl):3-7.

  4. Adler AI. Stevens RJ. Neil A. Stratton IM. Boulton AJ. Holman RR. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care. 2002; 25(5):894-9.

  5. Levy PJ, Hornung CA, Haynes JL, et al. Lower extremity ischemia in adults younger than forty years of age: a community-wide survey of premature atherosclerotic arterial disease. Journal of Vascular Surgery. 1994; (19):873-881.

  6. Barua RS. Ambrose JA. Saha DC. Eales-Reynolds LJ. Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration. Circulation. 2002; 106(8):905-8.

  7. Conklin BS, Zhao W, Zhong DS, Chen C. Nicotine and cotine upregulate vascular endothelial growth factor expression in endothelial cells. American Journal of Pathology. 2002; 160(2):413-8.

  8. Winther K. Fornitz GG. The effect of cigarette smoking and nicotine chewing gum on platelet function and fibrinolytic activity. Journal of Cardiovascular Risk. 1999; 6(5):303-6.

  9. Bloomgarden ZT. The European Association for the Study of Diabetes Annual Meeting, 1998: complications of diabetes. Diabetes Care. 1999; 22(8):1364-70.

  10. Dolan NC. Liu K. Criqui MH. Greenland P. Guralnik JM. Chan C. Schneider JR. Mandapat AL. Martin G. McDermott MM. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care. 2002; 25(1):113-20.

  11. Ness J. Aronow WS. Ahn C. Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice. Journal of the American Geriatrics Society. 2000; 48(3):312-4.

  12. Boers GH. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance. Thrombosis & Haemostasis. 1997; 78(1):520-2.

  13. Planas A. Clara A. Pou JM. Vidal-Barraquer F. Gasol A. de Moner A. Contreras C. Marrugat J. Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men. International Journal of Obesity & Related Metabolic Disorders. 2001; 25(7):1068-70.

  14. Dawson DL. Hiatt WR. Creager MA. Hirsch AT. Peripheral arterial disease: medical care and prevention of complications. Preventive Cardiology. 2002; 5(3):119-30.

  15. Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Medica Scandinavica. 1982; 211:249-256.

  16. Aronow WS. Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. American Journal of Cardiology. 1994; 74(1):64-5.

  17. Alexandrova NA. Gibson WC. Norris JW. Maggisano R. Carotid artery stenosis in peripheral vascular disease. Journal of Vascular Surgery. 1996; 23(4):645-9.

  18. Weitz JI. Byrne J. Clagett GP. Farkouh ME. Porter JM. Sackett DL. Strandness DE Jr. Taylor LM. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996; 94(11):3026-49.

  19. Mangano DT: Perioperative cardiac morbidity. Anesthesiology. 1990; 72:153-84.

  20. Rojas G.A., Cervantes J., Reyes E., Huerta M., Ramirez O., Chiapa M., Rubio R., Insuficiencia arterial embolica aguda. Revista Mexicana de Angiología. 2002; 30(1).

  21. Dormandy J., Heeck L., Vig S. Acute limb ischemia. Seminars in Vascular Surgery. 1999; 12: 148-53.

  22. O´Mara CS. Peripheral arterial embolus. En: Cameron JL. Current Surgical Therapy. St. Louis Missouri: Mosby; 1998.

  23. Blebea J, Kempozinsky RF. Acute limb isquemia. En: ST. Yao J and Brewster DC. Current diagnosis and treatment in vascular surgery. East Norwalk, Connecticut: Appleton & Lange; 1995.

  24. Hobson RW. Introduction: Acute limb ischemia. Seminars in Vascular Surgery. 1992; 5:1-3.

  25. Desborough J.P., Hall G.M., Endocrine response to surgery. Dr. Kaufman L., Anaesthesia Review, vol. 10. Edinburg: Churchill Livingstone 1993; 131-48.

  26. Desborough J.P., The stress response to trauma and surgery. British Journal of Anaesthesia. 2000; 85:109-17.

  27. Markovic S., Knight P., Murasko D.: Inhibition of Interferon Stimulation of Natural Killer Cell Activity in Mice Anesthetized with Halothane or Isoflurane. Anesthesiology 1993; 78:700-706.

  28. Duncan P and Cullen B.: Anesthesia and Immunology. Anesthesiology 1976; 45:522-538.

  29. Salo M. Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiologica Scandinavica. 1992; 36(3):201-20.

  30. Markovic S. And Murasko D.: Role of Natural Killer and T-Cells in Interferon Induced Inhibition of Spontaneous Metastases of the B16F110L Murine Melanoma. Cancer Research 1991; 51:1124-1128.

  31. Yeager MP. Procopio MA. DeLeo JA. Arruda JL. Hildebrandt L. Howell AL. Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16(+) lymphocytes in humans. Anesthesia & Analgesia. 2002; 94(1):94-9.

  32. Kutza J. Gratz I. Afshar M. Murasko DM. The effects of general anesthesia and surgery on basal and interferon stimulated natural killer cell activity of humans. Anesthesia & Analgesia. 1997; 85(4):918-23.

  33. Markovic S., Nurasko D.: Inhibition of Induction of Natural Killer Activity in Mice by General Ansthesia (Avertin): Role of Interferon. Clin Immunol Immunolpathol 1991; 60:181-189.

  34. Perttila J. Salo M. Vuori A. Heikela A. Effects of various ventilation modes on immunocompetence in surgical patients. Acta Anaesthesiologica Scandinavica. 1989; 33(5):348-52.

  35. Moore T.: Anesthesia-Associated Depression in Lymphocyte Traffic and its Modulation. American Journal of Surgery 1984; 147:807-812.

  36. Moore T., Spruck C., Leduc L.: Depression of Lymphocyte Traffic in Sheep by Anesthesia and Associated Changes in Enfrent-Lymph PGE2 and Antibody Levels. Immunology 1988; 63:139-143.

  37. Pollock R., Lotzova E, Stanford S.: Mechanism of Surgical Stress Impairment of Human Perioperative Natural Killer Cell Cytotoxicity. Archives of Surgery 1991; 126:338.342.

  38. Pollock R., Babock G., Romsdahl M., et. Al: Surgical Stress Mediated Supression of Murine Natural Killer Cell Cytotoxicity. Cancer Research 1984; 44:3888-3891.

  39. Walton B. Effects of anaesthesia and surgery on immune status. British Journal of Anaesthesia. 1979; 51(1):37-43.

  40. Tonnesen E. Brinklov MM. Christensen NJ. Olesen AS. Madsen T. Natural killer cell activity and lymphocyte function during and after coronary artery bypass grafting in relation to the endocrine stress response. Anesthesiology. 1987; 67(4):526-33.

  41. Crary B. Hauser SL. Borysenko M. Kutz I. Hoban C. Ault KA. Weiner HL. Benson H. Epinephrine-induced changes in the distribution of lymphocyte subsets in peripheral blood of humans. Journal of Immunology. 1983; 131(3):1178-81.

  42. Kotani N. Hashimoto H. Sessler DI. Kikuchi A. Suzuki A. Takahashi S. Muraoka M. Matsuki A. Intraoperative modulation of alveolar macrophage function during isoflurane and propofol anesthesia Anesthesiology. 1998; 89(5):1125-32.

  43. Procopio MA. Rassias AJ. DeLeo JA. Pahl J. Hildebrandt L. Yeager MP. The in vivo effects of general and epidural anesthesia on human immune function. Anesthesia & Analgesia. 2001; 93(2):460-5.

  44. Tracey K.J. and Cerami A.: Tumor Necrosis Factor: An Update Review of its Biology. Critical Care Medicine 1989; 17:489-494.

  45. Reyes-Terán G. Y Llorente L.: Sepsis y Choque Séptico: Nuevas Modalidades Terapéuticas. Inflamación 1992; 3:523-536.

  46. Deitch E., Dazhong X. And Berg R.: Bacterial Translocation from the Gut Impairs Systemic Inmunity Surgery. 1991; 109:269-276.

  47. Duncan P., Cullen B.: Anesthesia and the Modification of Response to Infection in Mice Anesthesia & Analgesia. Nov.-Dic., 1976.

  48. Santoli D. Trinchieri G. Koprowski H. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. Journal of Immunology. 1978; 121(2):532-8.

  49. Ogburn C.A., Berg K., Paucer K.: Purification of Mouse Interferon by Affinity Chromatography on Anti-Interferon Globulin-Separose. J. Immunology1973; 111:1206-1218.

  50. Collins GJ, Barber JA, Zajtchuk R, et al. The effects of operative stress on the coagulation profile. American Journal of Surgery 1977; 133: 612-6.

  51. Donadoni R, Baele G, Devulder J, Rolly G. Coagulation and fibrinolytic parameters in patients undergoing total hip replacement: influence of the anaesthesia technique. Acta Anaesthesiologica Scandinavica. 1989; 33: 588-92.

  52. Christopherson R, Beattie C, Frank SM, et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lowerextremity vascular surgery: Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology. 1993; 79: 422-34.

  53. Tuman KJ, McCarthy RJ, March RJ, et al. Effects of epidural anesthesia and analgesia on coagulation and outcome after major vascular surgery. Anesthesia & Analgesia. 1991; 73: 696-704.

  54. Andersson TR, Berner NS, Larsen ML, et al. Plasma heparin cofactor II, protein C and antithrombin in elective surgery. Acta Chirurgica Scandinavica. 1987; 153: 291-6.

  55. Breslow MJ, Parker SD, Frank SM, et al. Determinants of catecholamine and cortisol responses to lower-extremity revascularization: The PIRAT Study Group. Anesthesiology. 1993; 79: 1202-9.

  56. Blaise GA, Parent M, Laurin S, et al. Platelet-induced vasomotion of isolated canine coronary artery in the presence of halothane and isoflurane. Journal of Cardiothoracic and Vascular Anesthesia 1994; 8: 175-81.

  57. Yamamoto Y, Kamiya K, Terao S. Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction. Journal of Medicinal Chemistry 1993; 36: 820-5.

  58. McDaniel MD, Pearce WH, Yao JST, et al. Sequential changes in coagulation and platelet function following femorotibial bypass. Journal of Vascular Surgery 1984; 1: 261-8.

  59. Hahnenkamp K. Theilmeier G. Van Aken HK. Hoenemann CW. The effects of local anesthetics on perioperative coagulation, inflammation, and microcirculation. Anesthesia & Analgesia.2002; 94(6):1441-7.

  60. Rosenfeld BA, Beattie C, Christopherson R, et al. The effects of different anesthetic regimes on fibrinolysis and the development of postoperative arterial thrombosis: Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology . 1993; 79: 435-43.

  61. Modig J, Maripuu E, Sahlstedt B. Thromboembolism following total hip replacement: a prospective investigation of 94 patients with emphasis on the efficacy of lumbar epidural anesthesia in prophylaxis. Regional Anesthesia. 1986; 11: 72-9.

  62. Dinarello Ch.A. Impact of basis research on tomorrow´s medicine. Proinflammatory cytokines. Chest, 2000; 118 (2); 503-8.

  63. Desborough JP, Hall GM. Modification of the hormonal and metabolic response to surgery by narcotics and general anaesthesia. Clin Anaesthesiol. 1989; 3: 317-34.

  64. Grass J.A., The role of epidural anesthesia and analgesia in postoperative outcome. Anesthesiology Clinics of North America. 2000; 18(2).

  65. Bredbacka S, Blomback M, Hagnevik K, et al. Pre- and postoperative changes in coagulation and fibrinolytic variables during abdominal hysterectomy under epidural or general anaesthesia. Acta Anaesthesiologica Scandinavica 1986; 30: 204-10.

  66. Modig J, Borg T, Bagge L, Saldeen T. Role of extradural and general anaesthesia in fibrinolysis and coagulation after total hip replacement. British Journal of Anaesthesia. 1983; 55: 625-9.

  67. Henny CP, Odoom JA, Ten Cate JW, et al. Effects of extradural bupivacaine on the haemostatic system. British Journal of Anaesthesia. 1986; 58: 301-5.

  68. Odoom JA, Dokter PW, Sturk A, et al. The influence of epidural analgesia on platelet function and correlation with plasma bupivacaine concentrations. European Journal of Anaesthesiology. 1988; 5: 305-12.

  69. Hollmann MW, Wieczorek KS, Smart M, Durieux ME. Epidural anesthesia prevents hypercoagulation in patients undergoing major orthopedic surgery. Regional Anesthesia and Pain Medicine. 2001; 26: 215-22.

  70. Schneider F. Bohner H. Habel U. Salloum JB. Stierstorfer A. Hummel TC. Miller C. Friedrichs R. Muller EE. Sandmann W. Risk factors for postoperative delirium in vascular surgery. General Hospital Psychiatry. 2002; 24(1):28-34.

  71. Elwood PC. Pickering J. Bayer A. Gallacher JE. Vascular disease and cognitive function in older men in the Caerphilly cohort. Age & Ageing. 2002; 31(1):43-8.

  72. Tuman KJ. McCarthy RJ. March RJ. DeLaria GA. Patel RV. Ivankovich AD. Effects of epidural anesthesia and analgesia on coagulation and outcome after major vascular surgery Anesthesia & Analgesia. 1991; 73(6):696-704.

  73. Ballantyne JC. Carr DB. deFerranti S. Suarez T. Lau J. Chalmers TC. Angelillo IF. Mosteller F. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative metaanalyses of randomized, controlled trials. Anesthesia & Analgesia. 1998; 86(3):598-612.

  74. Liu S. Carpenter RL. Neal JM. Epidural anesthesia and analgesia. Their role in postoperative outcome. Anesthesiology. 1995; 82(6):1474-506.

  75. Horlocker TT. Complications of spinal and epidural anesthesia. Anesthesiology Clinics of North America. 18(2):461-85, 2000.

  76. Pegues DA, Carr DB, Hopkins CC: Infectious complications with temporary epidural catheters. Clinical Infectious Diseases 1994; 19:970-2.

  77. Yeager MP. Glass DD. Neff RK. Brinck-Johnsen T. Epidural anesthesia and analgesia in high-risk surgical patients. Anesthesiology. 1987; 66(6):729-36.

  78. Christopherson R., Beattie Ch., Steven M.F., et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Anesthesiology. 1993; 79:422-434.

  79. Bode RH Jr. Lewis KP. Zarich SW. Pierce ET. Roberts M. Kowalchuk GJ. Satwicz PR. Gibbons GW. Hunter JA. Espanola CC. Cardiac outcome after peripheral vascular surgery. Comparison of general and regional anesthesia Anesthesiology. 1996; 84(1):3-13.

  80. De Leon-Casasola OA. Lema MJ. General versus regional anesthesia for peripheral vascular surgery. Anesthesiology. 1996; 85(1):224-5.

  81. Mangano DT. Siliciano D. Hollenberg M. Leung JM. Browner WS. Goehner P. Merrick S. Verrier E. Postoperative myocardial ischemia. Therapeutic trials using intensive analgesia following surgery. The Study of Perioperative Ischemia (SPI) Research Group. Anesthesiology. 1992; 76(3):342-53.

  82. de Leon-Casasola OA. Lema MJ. Karabella D. Harrison P. Postoperative myocardial ischemia: epidural versus intravenous patient-controlled analgesia. A pilot project. Regional Anesthesia. 1995; 20(2):105-12.

  83. Sprung J. Abdelmalak B. Gottlieb A. Mayhew C. Hammel J. Levy PJ. O’Hara P. Hertzer NR. Analysis of risk factors for myocardial infarction and cardiac mortality after major vascular surgery. Anesthesiology. 2000; 93(1):129-40.

  84. Hultgren R. Olofsson P. Wahlberg E. Sex-related differences in outcome after vascular interventions for lower limb ischemia. Journal of Vascular Surgery. 2002; 35(3):510-6.

  85. Rossi E. Biasucci LM. Citterio F. Pelliccioni S. Monaco C. Ginnetti F. Angiolillo DJ. Grieco G. Liuzzo G. Maseri A. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation. 2002; 105(7):800-3.

  86. L’Italien GJ. Paul SD. Hendel RC. Leppo JA. Cohen MC. Fleisher LA. Brown KA. Zarich SW. Cambria RP. Cutler BS. Eagle KA. Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1,081 vascular surgical candidates. Journal of the American College of Cardiology. 1996; 27(4):779-86.

  87. Morales PA. Heuser RR. Peripheral vascular disease: perspectives on aortoiliac, renal, and femoral treatments using catheter-based techniques. Journal of Interventional Cardiology. 14(6):629-37, 2001.

  88. White CJ. Non-surgical treatment of patients with peripheral vascular disease. British Medical Bulletin. 2001; 59:173-92.

  89. Fowkes FGR, Gillespie IN. Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database of Systematic Reviews. (4), 2002.

  90. Stuhmeier KD. Mainzer B. Cierpka J. Sandmann W. Tarnow J. Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology. 1996; 85(4):706-12.

  91. McDermott MM. Peripheral arterial disease: epidemiology and drug therapy. American Journal of Geriatric Cardiology. 2002; 11(4):258-66.

  92. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360(9326):7-22.

  93. Jepson RG, Klejinen J, Leng GC. Garlic for Peripheral arterial occlusive disease. Cochrane Database of Systematic Reviews. (4) 2002.

  94. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360(9326):23-33.

  95. Jackson G. Simvastatin and impotence. British Medical Journal. 1997; 315: 31.

  96. Shlansky-Goldberg R. Platelet aggregation inhibitors for use in peripheral vascular interventions: what can we learn from the experience in the coronary arteries?. Journal of Vascular & Interventional Radiology. 13(3):229-46, 2002.

  97. Rocha-Singh KJ, Trokey J. Combined glycoprotein Iib/IIIa receptor inhibition and low-dose fibrinolysis for peripheral arterial thrombosis. Catheterization & Cardiovascular interventions 55(4); 457-60, 2002.

  98. Campbell WB. France F. Goodwin HM. Research and Audit Committee of the Vascular Surgical Society of Great Britain and Ireland. Medicolegal claims in vascular surgery. Annals of the Royal College of Surgeons of England. 84(3):181-4, 2002.




2020     |     www.medigraphic.com